Loxo Oncology Shares Volatile, Now Largely Unch Following News Co.'s LOXO-101 Showed Encouraging Initial Results from Ongoing Phase 1a Study
April 21, 2015 at 13:13 PM EDT
Loxo Oncology, Inc. (Nasdaq: LOXO), a biopharmaceutical company focused on the discovery, development, and commercialization of ...
